Abstract:The purpose of the present study was to prepare a clonidine hydrochloride (CH) sustained-release suspension.The processes involved in the drug formulation included drug loading, impregnating, and suspension preparation. Clonidine hydrochloride drug–resin complexes (CH-DRC) were prepared using the bath method and the CH-DRC impregnated before the microencapsulation process. Based on the bottom spray fluidized bed coating method, the CH microencapsulated drug–resin complexes (CH-MC) were also prepared using Surelease® (the suspension of ethyl cellulose aqueous dispersion) as the coating material. The effects of coating (process/formulation) on the in vitro release of coating microcapsule were evaluated via single factor investigation and orthogonal design optimization. The CH-MC with optimized formulation was further dispersed in a suitable medium to obtain a sustained-release suspension. Rats were given commercial CH ordinary tablets and the CH sustained-release suspension via intragastric administration. The plasma concentration–time curve and related pharmacokinetic parameters were investigated using the non-compartment model.The Tmax of the CH sustained-release suspension was delayed from 2 h to 5 h compared with the CH ordinary tablets. Similarly, the Cmax was reduced from 32.138 µg·mL−1 to 18.150 µg·mL−1 with the concentration–time curve being more gentle compared with the commercially CH ordinary tablets. After oral administration, the relative bioavailability of CH sustained-release suspension (AUC0–24 of 137.703 µg·h·mL−1) to its CH ordinary tablets (AUC0–24 of 123.337 µg·h·mL−1) was 111.65%.The findings showed that the CH sustained-release suspension for oral administration was successfully formulated.

Study on Formula and Preparation Technology of Gliclazide Sustained-release Tablets

Study on pramipexole dihydrochloride sustained-release tablets

Preparation and in vitro Dissolution of Gliclazide Sustained-release Tablets

Preparation of Captopril Delayed-Onset, Sustained Release Tablets

Glycyrrhizic Acid-Phospholipid Complex: Preparation Process Optimization and Therapeutic and Pharmacokinetic Evaluation in Rats

Preparation and Quality Control of Levamlodipine Besylate Orally Disintegrating Tablets

Preparation of Sustained Release Capsules by Electrostatic Dry Powder Coating, Using Traditional Dip Coating As Reference

Optimal formulation and technology of captopril sustained-release tablet

Preparation and in Vitro Release Study of Sodium Ferulate Gastric Floating Tablets

[Research on preparation of Shandantong sustained-release tablets]

On Formula Optimization for Valaciclovir Dispersible Tablets

Preparation of Compound Sodium Ferulate-gastrodin Quick-release Double-layer Tablets

Formula Screening and Optimizing for the Dispersible Tablets of Breviscapinum

Preparation and in vitro/in vivo evaluation of a clonidine hydrochloride drug–resin suspension as a sustained-release formulation

Bioequivalence of Glipizide Controlled-Release Tablets in Chinese Healthy Volunteers

Optimization of the composition and technology for the production of flotation tablets of sitagliptin with modified release

Optimization of Preparation Process and Pharmacokinetics of APAP Double-Release Pellet Capsules

Studies on Preparation and in vitro Drug Release of Sodium Ferulate Double-layer Tablets

Effects of Processing on a Sustained Release Formulation Prepared by Twin-Screw Dry Granulation

Evaluation of the Bioequivalence and Pharmacokinetics of Two Formulations of Gliclazide in Healthy Chinese Volunteers Using Population Pharmacokinetic Approach

Preparation and evaluation on sustained-release pellets containing total lactones of Ginkgo biloba